Investigating the Therapeutic Mechanisms and Key Bioactive Compounds of Solanum nigrum in Treating Psoriatic Lesions - Top-Institutions - MDSpire

Investigating the Therapeutic Mechanisms and Key Bioactive Compounds of Solanum nigrum in Treating Psoriatic Lesions

  • By

  • Ya Chen

  • Tianyou Ma

  • Congcong Zhu

  • Zongguang Tai

  • Huijun Pan

  • Zhongjian Chen

  • Quangang Zhu

  • April 24, 2026

  • 0 min

Share

Top Institutions in Dermatology

Brief introduction explaining scope and methodology.

  • #1

    National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), NIH
    National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), NIH

    Bethesda, MD

    Key Differentiators

    • Dermatology
    • Immunology
    • Inflammation Research

  • #2

    Department of Dermatology, University of California, San Francisco (UCSF)
    Department of Dermatology, University of California, San Francisco (UCSF)

    San Francisco, CA

    Key Differentiators

    • Dermatology
    • Molecular Immunology
    • Translational Medicine

  • #3

    Department of Dermatology, Harvard Medical School / Massachusetts General Hospital
    Department of Dermatology, Harvard Medical School / Massachusetts General Hospital

    Boston, MA

    Key Differentiators

    • Dermatology
    • Immunology
    • Pharmacology

  • #4

    Department of Dermatology, University of Michigan
    Department of Dermatology, University of Michigan

    Ann Arbor, MI

    Key Differentiators

    • Dermatology
    • Immunology
    • Bioinformatics

  • #5

    Department of Dermatology, University of Pennsylvania
    Department of Dermatology, University of Pennsylvania

    Philadelphia, PA

    Key Differentiators

    • Dermatology
    • Immunology
    • Clinical Research

Original Source(s)

Investigating the Therapeutic Mechanisms and Key Bioactive Compounds of Solanum nigrum in Treating Psoriatic Lesions

  • by Ya Chen, Tianyou Ma, Congcong Zhu, Zongguang Tai, Huijun Pan, Zhongjian Chen, Quangang Zhu

  • April 24, 2026

Related Content

Understanding the Perspectives and Experiences of Canadian Psoriasis Patients with Diverse Skin Tones

The Loan Cap That Could Shrink the Doctor Pipeline

New federal limits on medical school borrowing may quietly reshape who becomes a physician—and where they practice.

Psoriasis as a systemic inflammatory disease: an immune set-point framework for comorbidities and relapse